Skip to main content
. 2023 Jul 6;20(7):e1004253. doi: 10.1371/journal.pmed.1004253

Table 2. Tested women, by age and screening history.

Intervention group Reference group
Eligible women N Total tested
n (% of eligible)
Clinician-based sampling
n (% of total tested)
Self-sampling
n (% of total tested)
Eligible women
N
Total tested*
n (% of eligible)
11,192 6,965 (62.2) 4,955 (71.1) 2,010 (28.9) 33,387 743 (2.2)
Age groups (years)
65–67 4,262 2,594 (60.9) 1,831 (70.6) 763 (29.4) 11,589 312 (2.7)
68–69 6,930 4,371 (63.1) 3,124 (71.5) 1,247 (28.5) 21,798 431 (2.0)
Screening at age 50–64
Insufficiently screened (≤1 cervical sample) 2,665 443 (16.6) 212 (47.9) 231 (52.1) 7,636 65 (0.9)
Sufficiently screened (≥2 cervical samples) 8,527 6,522 (76.5) 4,743 (72.7) 1,779 (27.3) 25,751 678 (2.6)

Data are provided as numbers (row percent).

*All clinician-based sampling.